NUCB2 and type 2 diabetes mellitus: Regarding serum nesfatin-1 level, our study was in line with previous studies as those conducted by Li et al. [22] and Kadim and Hassan [23], which showed significantly lower nesfatin-1 in the T2DM patients in comparison to the control group.